Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Haematology

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2009.07720.xPMID 19438482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Labeling of Multiple Cell Markers and mRNA Using Automated Apparatus

  2008cited by this paper
• NF-κB regulates Lef1 gene expression in chondrocytes

  2007cited by this paper
• Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients

  2007cited by this paper
• LEF‐1 Is a Decisive Transcription Factor in Neutrophil Granulopoiesis

  2007cited by this paper
• NF-kappaB regulates Lef1 gene expression in chondrocytes.

  2007cited by this paper
• LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

  2006cited by this paper
• Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

  2006cited by this paper
• Myelodysplastic syndrome.

  2005cited by this paper
• Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation

  2004cited by this paper
• Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology.

  2003cited by this paper
• Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the α-thalassemia myelodysplasia syndrome (ATMDS)

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Myelodysplasia

  2001cited by this paper
• Burkitt’s Lymphoma: A Single Disease With Multiple Variants

  1999cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• Myelodysplasia.

  1999cited by this paper
• Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes.

  1996cited by this paper

• Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms

  2024cites this paper
• Bioinformatics analysis deciphering the transcriptomic signatures associated with signalling pathways and prognosis in the myelodysplastic syndromes

  2022cites this paper
• Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

  2021cites this paper
• Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patients

  2020cites this paper
• LEF1‐AS1, long non‐coding RNA, inhibits proliferation in myeloid malignancy

  2019cites this paper
• Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients

  2019cites this paper
• Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway.

  2019cites this paper
• Lymphoid enhancer factor 1 gene expression in comparison to other prognostic markers in adult B-acute lymphoblastic leukemia

  2019cites this paper
• Molecular origin of childhood acute lymphoblastic leukemia

  2016cites this paper
• Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia

  2015cites this paper
• Prognostic Significance of Lymphoid Enhancer-Binding Factor-1 Expression in Egyptian Adult B-Acute Lymphocytic Leukemia Patients

  2015cites this paper
• Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?

  2014cites this paper
• Expression and Proliferation-Promoting Role of Lymphoid Enhancer-Binding Factor 1 in Human Clear Cell Renal Carcinoma

  2014cites this paper
• Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.

  2013cites this paper
• Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia

  2013cites this paper
• High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.

  2012influential citation
• Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

  2012cites this paper
• Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.

  2011influential citation
• 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.

  2011cites this paper
• Molecular Changes in Myelodysplastic Syndrome

  2011cites this paper
• The lower risk MDS patient at risk of rapid progression.

  2010cites this paper
• Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.

  2010cites this paper
• Prognostic molecular markers in myelodysplastic syndromes

  2009cites this paper